Cyclophosphamide 1gm Vial

Indications:

• Lymphomas (Hodgkin’s and non-Hodgkin’s).
• Leukemias (acute and chronic blood cancers).
• Multiple myeloma.
• Solid tumors such as breast cancer, ovarian cancer, and lung cancer.
• Sometimes used in bone marrow transplantation and autoimmune diseases (when prescribed by a specialist).

Administration:

• Supplied as a powder for injection or infusion. Must be dissolved in a suitable sterile solution before use.
• Administered by intravenous infusion or injection in a hospital or oncology clinic.
• Dosage depends on cancer type, treatment protocol, and patient factors (weight, kidney and liver function, blood counts).
• Patients are usually given adequate fluids and sometimes mesna to protect the bladder from irritation.

Safety Information:

• Contraindicated in patients allergic to cyclophosphamide or with severely suppressed bone marrow.
• Caution in patients with kidney or liver impairment, prior bladder problems, or low immunity.
• Common side effects: nausea, vomiting, loss of appetite, hair loss, fatigue, and increased risk of infection.
• Serious risks: bone marrow suppression, hemorrhagic cystitis (bladder toxicity), fertility issues, and long-term risk of secondary cancers.
• Requires regular blood counts, urine checks, and organ function monitoring during treatment.

Notice:
Cyclophosphamide 1g Vial is a prescription-only chemotherapy medicine. It must be prepared and administered exclusively by qualified oncology healthcare professionals in a controlled hospital setting.